CausalSentinel

Protein Dossier — APCS (Serum amyloid P-component)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: muscle or soft tissue injuries 0.286 0.0862 9.18e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis 0.0842 0.0297 0.00451 Wald ratio 1 cis NA
Low grade serous ovarian cancer 0.55 0.224 0.0139 Wald ratio 1 cis NA
Urate 0.049 0.0215 0.0227 Wald ratio 1 cis NA
Fasting proinsulin 0.0633 0.0287 0.0272 Wald ratio 1 cis NA
Red blood cell count -0.019 0.0092 0.0389 Wald ratio 1 cis NA
Schizophrenia 0.0839 0.0415 0.0431 Wald ratio 1 cis NA
Non-cancer illness code self-reported: ankylosing spondylitis 0.284 0.141 0.0436 Wald ratio 1 cis NA
Ischemic stroke -0.129 0.0646 0.0459 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years 0.0564 0.0284 0.047 Wald ratio 1 cis NA
Diagnoses - main ICD10: R55 Syncope and collapse -0.272 0.137 0.0473 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter -0.316 0.163 0.0516 Wald ratio 1 cis NA
…and 75 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2474_54_5 SAP Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

24 association rows across 16 traits (23 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
APCS protein levels 7e-144 rs36126250 3 GCST90468328 no MR -> candidate analysis
Serum amyloid P-component levels 1e-61 rs35737842 3 GCST90249426 no MR -> candidate analysis
C-reactive protein levels 8e-57 rs16842320 3 GCST009777 no MR -> candidate analysis
C-reactive protein levels (MTAG) 6e-49 rs61680681 2 GCST90179146 no MR -> candidate analysis
Circulating SPP1 levels 1e-27 rs28383572 1 GCST90859966 no MR -> candidate analysis
Phosphate levels (UKB data field 30810) 2e-27 rs28383573 1 GCST90468094 no MR -> candidate analysis
SLAMF8 protein levels 6e-27 rs138112491 1 GCST90470652 no MR -> candidate analysis
Serum levels of protein APCS 2e-25 rs28383573 1 GCST90087947 no MR -> candidate analysis
DNA methylation-estimated granulocyte proportions 5e-18 rs2808661 2 GCST90014293 no MR -> candidate analysis
SPP1 protein levels 1e-15 rs28383572 1 GCST90470733 no MR -> candidate analysis
C1QTNF5 protein levels 4e-15 rs35834732 1 GCST90468489 no MR -> candidate analysis
Aortic stenosis 9e-12 rs35485101 1 GCST90837551 no MR -> candidate analysis
…and 4 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 336 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
splenic disorder 0.363 common-variant locus no MR -> candidate analysis
restless legs syndrome 0.342 common-variant locus no MR -> candidate analysis
acute tonsillitis 0.342 common-variant locus no MR -> candidate analysis
bacterial infectious disease 0.207 common-variant locus no MR -> candidate analysis
inherited retinal dystrophy 0.195 common-variant locus no MR -> candidate analysis
pneumonia 0.107 common-variant locus no MR -> candidate analysis

Of the 6 rows above, 6 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 2 known modulators (Serum amyloid P-component)
gnomAD constraint pLI=0.11, LOEUF=2.53 — LoF-tolerant
GWAS Catalog 101 unique SNPs / 210 rows
ClinVar 46 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance